Markets

Stock Market Today: Strong July Jobs Report Has a Dark Side

A better-than-expected employment report that saw 1.8 million U.S. jobs added in July didn't give the markets much of a boost Friday.

Wall Street got the July jobs report it was hoping for, but the market didn't do much with it.

The Labor Department on Friday reported that the unemployment rate dropped to 10.2% last month, from 11.1% in June, as the U.S. added nearly 1.8 million jobs. That total was better than economists' estimates, though far lower than the 4.8 million jobs tacked on in June.

But investors didn't reap many gains in blue-chip stocks. While the small-cap Russell 2000 soared 1.6% to 1,569, the Dow Jones Industrial Average finished the day with a modest 0.2% improvement, and the S&P 500 inched ahead by a mere 2 points to 3,351.

The Nasdaq Composite fared much worse, declining by 0.9% to 11,010 as hot-running components such as Apple (AAPL, -2.3%), Microsoft (MSFT, -1.8%) and Amazon.com (AMZN, -1.8%) stalled out Friday.

"While the U.S. economy added more jobs and the unemployment rate fell (both better than expectations), the July increase in non-farm payrolls confirms that the rise in new virus cases did slow the economic recovery to some extent," writes Gene Goldman, chief investment officer at Cetera Investment Management, a broker-dealer network encompassing more than 8,000 advisors and $250 billion in assets. 

"One worry about today's report is that it puts less pressure on Washington to pass a much-needed, new fiscal stimulus package."

And, indeed, Congress appears to be at an impasse, with Republicans standing by their $1 trillion plan, and Democrats refusing to approve anything less than $2 trillion.

The Bright Side to Friday's Action

But some of the market's more troubled sectors of 2020 made a decent showing. Industrial stocks, for instance, finished with solid gains as UPS (UPS, +7.9%) continued its torrid run. Income-friendly real estate investment trusts (REITs) and utility stocks also picked up some slack.

Sitting somewhere in the middle, as it has throughout a good-but-not-great 2020, was the health care sector. While COVID-19 has hurt certain areas of health care as patients have put off general care and non-emergency procedures, it has sparked others – such as the biotech industry.

And on Friday, Biogen (BIIB) showed that there's plenty of gains to be made outside of coronavirus cures, shooting 10.1% higher on Friday on the back of positive news for its Alzheimer's treatment.

"This morning, (Biogen)/Eisai announced that the FDA accepted the biologics license application (BLA) and granted priority review for aducanumab (Alzheimer's disease)," writes Canaccord Genuity analyst Sumant Kulkarni. "We like the fact that BIIB earned this priority review vs. forcing one by utilizing a voucher that BIIB previously had. As we had (previously) surmised, we believe investors will view this "clean" grant of priority review as a potential indicator of FDA's receptivity towards the ... BLA."

Investors seeking growth often eyeball biotech stocks, which can generate sizzling swings on a single data release, but that's a double-edged sword that tends to cut deep.

The risk-averse can still tap into the profits created by biotechnological innovation through funds. Yes, these funds aren't going to double overnight like a few of their holdings might, but, by spreading their assets out across a few dozen stocks, they tamp down on risk and volatility while still providing exposure to outsize growth. Read on to learn more about the top biotech ETFs to buy.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
11 Best Monthly Dividend Stocks and Funds to Buy
Kiplinger's Investing Outlook

11 Best Monthly Dividend Stocks and Funds to Buy

Your bills come monthly. Why not your dividend checks? These are some of 2021's best monthly dividend stocks and funds for easier income planning.
May 25, 2021
4 Strategies to Reduce Taxes in Retirement
retirement planning

4 Strategies to Reduce Taxes in Retirement

Don’t let the possibility of higher taxes in the future sink your retirement income plan. Consider these four ways to help manage your taxes, keeping …
May 31, 2021

Recommended

Stock Market Today 6/11/21: Stocks Tread Water Ahead of June Fed Meeting
Stock Market Today

Stock Market Today 6/11/21: Stocks Tread Water Ahead of June Fed Meeting

The S&P 500 managed to eke out a new record high, while the Dow muscled its way into the green at the close.
June 11, 2021
The Next GameStop? 25 High Short Interest Stocks
stocks

The Next GameStop? 25 High Short Interest Stocks

A recent trading frenzy around heavily shorted stocks has targeted names such as these. But beware: The music could stop at any moment.
June 11, 2021
Stock Market Today 6/10/21: S&P 500 Sets New High as Inflation Stays Red-Hot
Stock Market Today

Stock Market Today 6/10/21: S&P 500 Sets New High as Inflation Stays Red-Hot

May's consumer price index (CPI) growth was even hotter than expected, but investors didn't shy from the news, pushing the S&P 500 just over the new-h…
June 10, 2021
All 30 Dow Jones Stocks Ranked: The Pros Weigh In
blue chip stocks

All 30 Dow Jones Stocks Ranked: The Pros Weigh In

The Dow Jones Industrial Average is made up of 30 blue chips that are tops in their industries. But some Dow Jones stocks are better opportunities tha…
June 10, 2021